U.S. General Merchandise and Department Stores Stock News

We feel now is a pretty good time to analyse Tenaya Therapeutics, Inc.'s ( NASDAQ:TNYA ) business as it appears the...

Over the last 7 days, the U.S. market has risen by 1.4%, contributing to a notable 19% increase over the past year, with earnings projected to grow annually by a similar rate in the coming years. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated label—can still offer intriguing opportunities for growth and value. This article will explore several penny stocks that exhibit financial strength and potential for long-term success amidst...

The United States market has shown robust performance, climbing 1.4% in the last week and rising 19% over the past year, with earnings projected to grow by a similar margin annually. In this thriving environment, identifying promising small-cap stocks that may not yet be on every investor's radar can offer unique opportunities for growth and diversification.

Over the last 7 days, the United States market has risen by 1.4%, contributing to a 19% increase over the past year, with earnings forecasted to grow annually by the same percentage. In this environment of growth, dividend stocks can offer investors a combination of income and potential appreciation, making them an attractive option for those looking to capitalize on both current yields and future earnings prospects.

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

We'd be surprised if Arqit Quantum Inc. ( NASDAQ:ARQQ ) shareholders haven't noticed that the General Counsel...

Index reshuffle and guidance put FedEx Freight Holding Company in focus FedEx Freight Holding Company (FDXF) has quickly drawn investor attention after its spinoff, with a shift into Russell midcap benchmarks, fresh earnings guidance and a fiscal year-end change shaping how the stock is viewed. See our latest analysis for FedEx Freight Holding Company. Despite a stream of developments, including guidance for the transition period and index reshuffling around Russell and S&P benchmarks, FedEx...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Some Charles River Laboratories International, Inc. ( NYSE:CRL ) shareholders may be a little concerned to see that the...

Insiders who bought American Vanguard Corporation ( NYSE:AVD ) stock in the last 12 months were richly rewarded last...

Crypto and blockchain related stocks are suddenly back in the spotlight after President Trump disclosed $1.4b in crypto earnings and his administration doubled down on a pro crypto, pro technology message. Falling energy prices, talk of real wage gains, and a government backed Trump Accounts program for child investors are all feeding fresh interest in listed companies tied to digital assets. This article explains how that backdrop connects to our Crypto and Blockchain Technology Stocks...

In June 2026, SFL Corporation Ltd. (NYSE:SFL) was added to multiple Russell growth and small-cap indices, including the Russell 2000 Growth and Russell 3000 Growth benchmarks. This broad index inclusion can expand SFL’s visibility to institutional investors and passive funds that track these benchmarks, potentially deepening its shareholder base. We’ll now examine how SFL’s broad Russell index inclusion may influence its investment narrative, particularly around liquidity and investor...

In June 2026, Global Ship Lease, Inc. agreed to purchase five additional mid-size, ultra-high-reefer, wide-beam containerships for about US$413 million, all backed by multi-year charters extending into 2029 and beyond. These vessels lift the company’s total newbuilding orderbook to 15 ships, which are collectively contracted to generate over US$1.00 billion in Adjusted EBITDA across their firm charter terms, reinforcing future cash flow visibility. We’ll now examine how this expanded...

The latest US China trade thaw has a clear gap: textiles and apparel remain under the same US tariffs on Chinese goods through 2027, while sectors like agriculture and large manufacturers take center stage for relief. With Chinese apparel shipments to the US down 51% in Q1 2026, some US based textile and apparel manufacturers sit in the middle of this policy divide. This article walks through 3 stocks exposed to this news, explains why the tariff backdrop matters to their businesses, and...

The Supreme Court’s decision to restrict the president’s power to fire Federal Reserve governors has pushed central bank independence back into the spotlight, and dividend investors are paying attention. When interest rate expectations and policy stability are in play, large cap dividend stocks with solid balance sheets can look very different from more speculative income ideas. This article looks at how that ruling and the ongoing tension between the White House and the Fed intersect with...

What the new defense and in flight connectivity orders mean for investors Gilat Satellite Networks (GILT) recently reported two sizeable contract wins: a multi million dollar SATCOM deal with a European Ministry of Defense and US$43 million in Sidewinder antenna orders from an in flight connectivity provider. Both contracts indicate ongoing demand for Gilat Satellite Networks solutions across commercial aviation and government defense clients, with scheduled deliveries extending over the next...

National Beverage (FIZZ) just wrapped up FY 2026 with fourth quarter revenue of US$297.1 million and basic EPS of US$0.43, alongside net income of US$40.3 million. This provides a clear snapshot of how the business is currently earning its money. Over recent quarters, the company has seen revenue move between US$264.6 million and US$330.5 million, with basic EPS ranging from US$0.42 to US$0.60. This gives investors a view of how the top line and per share earnings have tracked through the...

Nasdaq and NYSE are set to jointly ring the opening bell to launch the Trump Accounts initiative. The program introduces government-backed children's investment accounts funded with Treasuries and directed into broad-based index funds. The event is framed as a market wide milestone, with potential implications for trading activity, product demand, and retail participation. NasdaqGS:NDAQ enters this news cycle with its stock at $84.66 and a mixed recent track record, including a 9.0% gain...

Kymera Therapeutics stock has delivered a very strong 404.9% return over the past three years, yet the company currently screens as expensive on Simply Wall St’s valuation checks, raising the question of how much of the recent clinical progress is already reflected in the price. A roughly 4x gain over three years suggests investors have rapidly repriced Kymera Therapeutics on expectations that its drug pipeline can create meaningful long term value. Faster than expected enrollment in the...

Simply Good Foods stock has rebounded in the short term, but the longer history is much harsher, with the shares down around 63% over the past three years while broader valuation checks suggest the stock does not currently screen as a clear bargain. The roughly 63% share price decline over three years points to investors reassessing what they are willing to pay for Simply Good Foods. Future growth in branded snacking and effective cost control can support the valuation, but any slowdown in...

Jade Biosciences stock reacts to index reshuffle and board appointment Jade Biosciences (JBIO) just saw its index profile tilt toward growth benchmarks, coinciding with the appointment of seasoned immunology executive Mark Eisner, M.D., M.P.H., to the board of directors. See our latest analysis for Jade Biosciences. At a share price of $21.51, Jade Biosciences has given investors a 30 day share price return of 21.18% and a 1 year total shareholder return of 93.09%. This reflects momentum...

Revolution Medicines (NasdaqGS:RVMD) reported Phase 1/2 trial data for its RAS(ON) inhibitor combinations in metastatic pancreatic cancer. The investigational therapies, zoldonrasib with standard chemotherapy or daraxonrasib, showed strong antitumor activity and manageable safety in patients with RAS G12D metastatic pancreatic ductal adenocarcinoma. The results support ongoing and planned Phase 3 trials in both first line and previously treated settings, in an indication that currently lacks...

FMC stock is coming off a difficult stretch, with the share price well below past levels, yet both the intrinsic value estimate using a Discounted Cash Flow (DCF) approach and the market multiples currently point to the shares trading at a discount to underlying value. FMC shareholders have seen the stock decline 87.6% over the past 3 years, which puts the current valuation front and center for anyone considering whether the reset has gone too far. Recent steps to raise cash, including a...